Table 1 Demographic and Baseline Characteristics by Treatment Group for the Intent-to-Treat Population
BMAC | SVF | UCT | CSI | All subjects | |
|---|---|---|---|---|---|
n = 118 | n = 119 | n = 118 | n = 120 | n = 475 | |
Age (years) | |||||
Mean ± s.d. | 58.6 ± 7.3 | 58.2 ± 7.3 | 57.9 ± 8.2 | 58.3 ± 8.1 | 58.3 ± 7.7 |
≥ 60, n (%) | 61 (52%) | 56 (47%) | 54 (46%) | 58 (48%) | 229 (48%) |
< 60, n (%) | 57 (48%) | 63 (53%) | 64 (54%) | 62 (52%) | 246 (52%) |
BMI (kg m−2), n | 104 | 106 | 115 | 107 | 432 |
Mean ± s.d. | 30.6 ± 6.0 | 30.5 ± 6.4 | 30.9 ± 5.4 | 31.2 ± 6.2 | 30.8 ± 6.0 |
KL grade, n (%) | |||||
Grade 2 | 31 (26%) | 34 (29%) | 44 (37%) | 34 (28%) | 143 (30%) |
Grade 3 | 43 (36%) | 52 (44%) | 42 (36%) | 54 (45%) | 191 (40%) |
Grade 4 | 44 (37%) | 33 (28%) | 32 (27%) | 32 (27%) | 141 (30%) |
VAS - mean baseline | 58.1 | 53.8 | 54.3 | 59.9 | |
95% CI | 54.8-61.5 | 50.6-56.9 | 50.6-58.1 | 56.5-63.2 | |
KOOS pain - mean baseline | 53.1 | 55.2 | 55.2 | 50.5 | |
95% CI | 50.3–55.9 | 52.7–57.7 | 53.0–57.4 | 47.7–53.2 | |
Male, n (%) | 56 (48%) | 56 (47%) | 53 (45%) | 49 (41%) | 214 (45%) |
Female, n (%) | 62 (53%) | 63 (53%) | 65 (55%) | 71 (59%) | 261 (55%) |
